|
KR20200129817A
|
|
Compositions for preventing, ameliorating or treating osteoarthritis comprising Glycyrrhizia inflata extract
|
|
KR20190113598A
|
|
2-cyanopyrimidin-4-yl carbamate or urea derivative or its salt and pharmaceutical composition comprising the same
|
|
KR20200029751A
|
|
Vortioxetine nicotinate and processes for preparing the same
|
|
KR20200025690A
|
|
Eye drop formulation in the form of an aqueous solution comprising olopatadine or a pharmaceutically acceptable salt thereof in high concentration
|
|
KR20190103710A
|
|
Eye drop formulation in a solution form comprising a benzopyran derivative or pharmaceutically acceptable salt therof
|
|
KR20190073673A
|
|
Pyrrolo[2,3-d]pyrimidine derivative or its salt and pharmaceutical composition comprising the same
|
|
KR101731078B1
|
|
Bilayer tablets comprising bepotastine or its salt
|
|
KR20170095525A
|
|
Process for preparing telmisartan-containing tablets
|
|
KR20170061980A
|
|
Processes for purifying a benzopyran derivative, a crystalline form thereof, and processes for preparing the crystalline form
|
|
KR20160000957A
|
|
Pharmaceutical composition comprising amlodipine and olmesartan medoxomil
|
|
KR20130031313A
|
|
Pharmaceutical composition comprising risedronic acid or its salt and vitamin d
|
|
CN103282044A
|
|
Nanoemulsion-type ophthalmic composition
|
|
KR20110088474A
|
|
Pharmaceutical composition comprising bisphosphonate derivative and high amount of cholecalciferol
|
|
KR101119610B1
|
|
Opthalmic liquid composition comprising dorzolamide, timolol, and brimonidine
|
|
KR20120058029A
|
|
Pharmaceutical composition for nasal administration comprising mometasone furoate and azelastine hydrochloride
|
|
KR20120045282A
|
|
Pharmaceutical composition for preventing or treating glaucoma comprising vitis vinifera pip extract
|
|
KR20120032649A
|
|
Pharmaceutical composition for preventing or treating rheumatoid arthritis comprising vitis vinifera pip extract and rebamipide
|
|
KR20110100370A
|
|
Ophthalmic soultion comprising brimonidine tartrate
|
|
KR20110030852A
|
|
Pharmaceutical composition comprising bisphosphonate derivative and high amount of cholecalciferol
|
|
KR20110022220A
|
|
Tablets for oral administration comprising vitis vinifera pip extract
|
